Letter to Congress Opposing the Proposal to Grant Two Years of Exclusivity for Certain Over-the-Counter Drugs

November 20, 2017

View as PDF.

Public Citizen expressed concerns with the proposal to grant two years of exclusivity for certain over-the-counter (OTC) drugs that is included in the September 11, 2017, House of Representatives’ discussion draft of the Over-the-Counter Monograph Safety, Innovation, and Reform Act of 2017.
While Public Citizen supports many of the measures included in the Act that would enable the Food and Drug Administration to better ensure that OTC drugs are safe and effective, we are concerned that the proposal to grant two years of exclusivity for certain OTC drugs could have negative repercussions for consumers.

See Public Citizen’s other work on OTC drugs.